Elisabeth G.E. de Vries

Researcher Next ID · RN-003527

Researcher · Medicine

Stockholm, Sweden

Not currently recruitingFunding unknown

Research interests

Medicine

Radiopharmaceutical Chemistry and Applications

Medical Imaging Techniques and Applications

HER2/EGFR in Cancer Research

Monoclonal and Polyclonal Antibodies Research

Drug Transport and Resistance Mechanisms

iRECIST: guidelines for response criteria for use in trials testing immunotherapeutics
The Lancet Oncology · 2017 · https://doi.org/10.1016/s1470-2045(17)30074-8
RECIST 1.1—Update and clarification: From the RECIST committee
European Journal of Cancer · 2016 · https://doi.org/10.1016/j.ejca.2016.03.081
Response assessment criteria for brain metastases: proposal from the RANO group
The Lancet Oncology · 2015 · https://doi.org/10.1016/s1470-2045(15)70057-4
A standardised, generic, validated approach to stratify the magnitude of clinical benefit that can be anticipated from anti-cancer therapies: the European Society for Medical Oncology Magnitude of Clinical Benefit Scale (ESMO-MCBS)
Annals of Oncology · 2015 · https://doi.org/10.1093/annonc/mdv249
Everolimus for Advanced Pancreatic Neuroendocrine Tumors
New England Journal of Medicine · 2011 · https://doi.org/10.1056/nejmoa1009290

No projects listed.